Trade Summary

2 days ago, Benkowitz Michael, serving as Pres, COO at United Therapeutics Corp (UTHR), sold 22,500 shares at $502.79 per share, for a total transaction value of $11,312,710.00. Following this transaction, Benkowitz Michael now holds 2,648 shares of UTHR.

This sale represents a 89.00% decrease in Benkowitz Michael's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 29, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 30, 2025, 1 day after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.